Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma
Susanna Hilda Hutajulu,1 Johan Kurnianda,1 I Bing Tan,2,3 Jaap M Middeldorp4 1Department of Internal Medicine, Faculty of Medicine Universitas Gadjah Mada/Dr Sardjito General Hospital, Yogyakarta, Indonesia; 2Department of Ear, Nose and Throat, The Netherlands Cancer Institute/Antoni van L...
Main Authors: | Hutajulu SH, Kurnianda J, Tan IB, Middeldorp JM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/therapeutic-implications-of-epsteinndashbarr-virus-infection-for-the-t-peer-reviewed-article-TCRM |
Similar Items
-
The mechanism(s) of epstein-barr virus infection in nasopharyngeal carcinoma
by: Chen, Yue Qin, et al.
Published: (1994) -
Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
by: Pok Man Hau, et al.
Published: (2020-05-01) -
Link of Nasopharyngeal Carcinoma and Epstein-Barr Virus
by: Sugiyanto Sugiyanto, et al.
Published: (2018-10-01) -
Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein–Barr Virus Infection
by: Xintong Peng, et al.
Published: (2021-08-01) -
The effect of protoberberines on nasopharyngeal carcinoma with Epstein-Barr virus infection
by: none none, et al.